Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas J George
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
650 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Center-Metro Medical Center Bayamon
Bayamón, Puerto Rico
- Doctors Cancer Center
Manati, Puerto Rico
- Centro Comprensivo de Cancer de Upr
San Juan, Puerto Rico
- San Juan City Hospital
San Juan, Puerto Rico
- San Juan Community Oncology Group
San Juan, Puerto Rico
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Southern Cancer Center Pc-Mobile
Mobile, Alabama, United States
- Southern Cancer Center Pc-Providence
Mobile, Alabama, United States
- Southern Cancer Center Pc-Springhill
Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California, United States
- Ais Cancer Center at San Joaquin Community Hospital
Bakersfield, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Enloe Medical Center
Chico, California, United States
- City of Hope Corona
Corona, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente Dublin
Dublin, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Fresno Cancer Center
Fresno, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Jan 2017
- Primary completion
- 21 Apr 2020
- Completion
- 20 Sept 2023
- Last update posted
- 4 Dec 2025
- Registered enrollment
- 363
- Registry id
- NCT02921256
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.